U.S. market Closed. Opens in 2 hours 6 minutes

OTLK | Outlook Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-30
RevenueN/AN/AN/AN/A8.15M3.09M3.81M2.98M5.22M9.05M
Cost of Revenue44.19K204.69K262.14K554.07K23.80KN/AN/AN/AN/AN/A
Gross Profit-44.19K-204.69K-262.14K-554.07K8.12M3.09MN/AN/AN/AN/A
Operating Expenses53.13M63.07M51.73M36.31M29.33M32.73M39.69M54.74MN/AN/A
Selling, General & Admin26.67M20.74M13.05M8.08M5.52M14.23M15.88M21.64M12.91M7.32M
Research & Development26.45M42.33M38.96M26.34M23.81M18.50M23.81M33.10M38.88M14.12M
Other Operating Expenses-3.76M-882.90KN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-53.13M-63.07M-51.73M-36.84M-36.30M-29.64M-35.88M-51.76M-46.56M-12.39M
Other Expenses / Income-4.29M-2.98M-1.43M-1.67M-1.64M-204.62K-2.47M-1.47M-2.30M-901.05K
Before Tax Income-58.98M-66.05M-53.16M-38.51M-37.93M-33.74M-38.35M-53.23M-48.86M-13.29M
Income Tax Expenses3.00K2.80K2.00K-3.27M-3.41M-3.65M501.50K103.00K-190.11K439.02K
Net Income-58.98M-66.05M-53.16M-35.24M-34.52M-30.09M-38.85M-53.33M-47.39M-13.73M
Interest Expenses1.56M1.49M936.00K1.76M3.47M3.89M5.63M1.47M2.30M901.05K
Basic Shares Outstanding12.51M10.60M7.63M3.63M909.59K4.93M3.00M2.15M1.77M1.77M
Diluted Shares Outstanding12.51M10.60M7.63M3.63M909.59K4.93M3.01M2.15M1.77M1.77M
EBITDA-52.60M-62.91M-51.77M-36.31M-21.67M-26.59M-30.03M-49.36M-43.46M-11.51M
EBITDA Margin0.00%0.00%0.00%0.00%-265.98%-861.20%-787.87%-1,656.75%-832.72%-127.22%
EBIT-57.42M-64.56M-52.23M-36.76M-34.47M-29.85M-32.72M-51.76M-45.29M-12.39M
EBIT Margin0.00%0.00%0.00%0.00%-423.12%-966.75%-858.50%-1,737.10%-867.68%-136.92%
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙